Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Department of Justice
Express Scripts

Generated: March 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 088072

« Back to Dashboard

NDA 088072 describes QUINIDINE SULFATE, which is a drug marketed by Lilly, G And W Labs Inc, Barr, Contract Pharmacal, Cycle Pharms Ltd, Dava Pharms Inc, Elkins Sinn, Everylife, Halsey, Hikma Pharms, Impax Labs, Ivax Sub Teva Pharms, King Pharms, Kv Pharm, Lannett, Lederle, Perrigo, Pharmavite, Purepac Pharm, Sandoz, Scherer Labs, Sun Pharm Industries, Superpharm, Usl Pharma, Valeant Pharm Intl, Vangard, Vintage Pharms, Warner Chilcott, Watson Labs, and Whiteworth Town Plsn, and is included in forty NDAs. It is available from three suppliers. Additional details are available on the QUINIDINE SULFATE profile page.

The generic ingredient in QUINIDINE SULFATE is quinidine sulfate. There are twenty-six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the quinidine sulfate profile page.
Summary for 088072
Ingredient:quinidine sulfate
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 088072
Suppliers and Packaging for NDA: 088072
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
QUINIDINE SULFATE quinidine sulfate TABLET;ORAL 088072 ANDA Eon Labs, Inc. 0185-1047 N 0185-1047-10
QUINIDINE SULFATE quinidine sulfate TABLET;ORAL 088072 ANDA Eon Labs, Inc. 0185-1047 N 0185-1047-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength300MG
Approval Date:Sep 26, 1983TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength200MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Farmers Insurance
Johnson and Johnson
Federal Trade Commission
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.